The protective role of natural phytoalexin resveratrol on inflammation, fibrosis and regeneration in cholestatic liver injury

Molecular Nutrition and Food Research

Volumn 55, Issue 12, 2011, Pages 1841-1849

  Chan, Che Chang ^a,b   Cheng, Ling Yi ^a,b   Lin, Chin Lung ^a,c   Huang, Yi Hsiang ^a,b   Lin, Han Chieh ^a   Lee, Fa Yauh ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAOYUAN ARMED FORCES GENERAL HOSPITAL   (Taiwan)

Author keywords

Hepatocyte; Inflammation; Kupffer cell; Regeneration; Resveratrol

Indexed keywords

4 HYDROXYNONENAL; 4-HYDROXY-2-NONENAL; ALDEHYDE; COLLAGEN TYPE 1; INTERLEUKIN 6; MESSENGER RNA; RESVERATROL; STILBENE DERIVATIVE; TIMP1 PROTEIN, MOUSE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BILE DUCT; C57BL MOUSE; CELL PROLIFERATION; CHOLESTASIS; DRUG EFFECT; GENETICS; INFLAMMATION; KUPFFER CELL; LIGATION; LIVER CELL; LIVER CIRRHOSIS; METABOLISM; MOUSE; PATHOLOGY;

ALDEHYDES; ANIMALS; BILE DUCTS; CELL PROLIFERATION; CHOLESTASIS; COLLAGEN TYPE I; HEPATOCYTES; INFLAMMATION; INTERLEUKIN-6; KUPFFER CELLS; LIGATION; LIVER CIRRHOSIS; MICE; MICE, INBRED C57BL; RNA, MESSENGER; STILBENES; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82955165813     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201100374     Document Type: Article

References (50)

1. Taub, R., Liver regeneration: from myth to mechanism. Nat. Rev. Mol. Cell Biol. 2004, 5, 836-847.
2. Rutherford, A., Chung, R. T., Acute liver failure: Mechanisms of hepatocyte injury and regeneration. Semin. Liver Dis. 2008, 28, 167-174.
3. Zhang, B. J., Xu, D., Guo, Y., Ping, J. et al., Protection by and anti-oxidant mechanism of berberine against rat liver fibrosis induced by multiple hepatotoxic factors. Clin. Exp. Pharmacol. Physiol. 2008, 35, 303-309.
4. Grattagliano, I., Bonfrate, L., Diogo, C. V., Wang, H. H. et al., Biochemical mechanisms in drug-induced liver injury: certainties and doubts. World J. Gastroenterol. 2009, 15, 4865-4876.
5. Lotersztajn, S., Julien, B., Teixeira-Clerc, F., Grenard, P., Mallat, A., Hepatic fibrosis: molecular mechanisms and drug targets. Annu. Rev. Pharmacol. Toxicol. 2005, 45, 605-628.
6. Ramm, G. A., Carr, S. C., Bridle, K. R., Li, L. et al., Morphology of liver repair following cholestatic liver injury: resolution of ductal hyperplasia, matrix deposition and regression of myofibroblasts. Liver 2000, 20, 387-396.
7. Winwood, P. J., Arthur, M. J., Kupffer cells: Their activation and role in animal models of liver injury and human liver disease. Semin. Liver Dis. 1993, 13, 50-59.
8. Jaeschke, H., Gores, G. J., Cederbaum, A. I., Hinson, J. A. et al., Mechanisms of hepatotoxicity. Toxicol. Sci. 2002, 65, 166-176.
9. Bruck, R., Shirin, H., Aeed, H., Matas, Z. et al., Prevention of hepatic cirrhosis in rats by hydroxyl radical scavengers. J. Hepatol. 2001, 35, 457-464.
10. Gehring, S., Dickson, E. M., San Martin, M. E., van Rooijen, N. et al., Kupffer cells abrogate cholestatic liver injury in mice. Gastroenterology 2006, 130, 810-822.
11. Friedman, S. L., Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 2000, 275, 2247-2250.
12. Sudo, K., Yamada, Y., Saito, K., Shimizu, S. et al., TNF-alpha and IL-6 signals from the bone marrow derived cells are necessary for normal murine liver regeneration. Biochim. Biophys. Acta 2008, 1782, 671-679.
13. Bhat, K. P. L., Kosmeder, J. W., II, Pezzuto, J. M., Biological effects of resveratrol. Antioxid. Redox. Signal. 2001, 3, 1041-1064.
14. Cai, Y. J., Wei, Q. Y., Fang, J. G., Yang, L. et al., The 3, 4-dihydroxyl groups are important for trans-resveratrol analogs to exhibit enhanced antioxidant and apoptotic activities. Anticancer Res. 2004, 24, 999-1002.
15. Leiro, J., Alvarez, E., Arranz, J. A., Laguna, R. et al., Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J. Leukoc. Biol. 2004, 75, 1156-1165.
16. Losso, J. N., Truax, R. E., Richard, G., trans-resveratrol inhibits hyperglycemia-induced inflammation and connexin downregulation in retinal pigment epithelial cells. J. Agric. Food Chem. 2010, 58, 8246-8252.
17. Bereswill, S., Munoz, M., Fischer, A., Plickert, R. et al., Anti-inflammatory effects of resveratrol, curcumin and simvastatin in acute small intestinal inflammation. PLoS One 2010, 5, e15099.
18. Martin, A. R., Villegas, I., Sanchez-Hidalgo, M., de la Lastra, C. A., The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model. Br. J. Pharmacol. 2006, 147, 873-885.
19. Wong, Y. T., Gruber, J., Jenner, A. M., Tay, F. E., Ruan, R., Chronic resveratrol intake reverses pro-inflammatory cytokine profile and oxidative DNA damage in ageing hybrid mice. Age (Dordr) 2011, 33, 229-246.
20. Li, J., Qu, X., Ricardo, S. D., Bertram, J. F., Nikolic-Paterson, D. J., Resveratrol inhibits renal fibrosis in the obstructed kidney: potential role in deacetylation of Smad3. Am. J. Pathol. 2010, 177, 1065-1071.
21. Wu, C. T., Yu, H. P., Chung, C. Y., Lau, Y. T., Liao, S. K., Attenuation of lung inflammation and pro-inflammatory cytokine production by resveratrol following trauma-hemorrhage. Chin. J. Physiol. 2008, 51, 363-368.
22. Chavez, E., Reyes-Gordillo, K., Segovia, J., Shibayama, M. et al., Resveratrol prevents fibrosis, NF-kappaB activation and TGF-beta increases induced by chronic CCl4 treatment in rats. J. Appl. Toxicol. 2008, 28, 35-43.
23. Penumathsa, S. V., Maulik, N., Resveratrol: A promising agent in promoting cardioprotection against coronary heart disease. Can. J. Physiol. Pharmacol. 2009, 87, 275-286.
24. Cui, J., Sun, R., Yu, Y., Gou, S. et al., Antiproliferative effect of resveratrol in pancreatic cancer cells. Phytother. Res. 2010, 24, 1637-1644.
25. Ara, C., Kirimlioglu, H., Karabulut, A. B., Coban, S. et al., Protective effect of resveratrol against oxidative stress in cholestasis. J. Surg. Res. 2005, 127, 112-117.
26. Kirimlioglu, V., Ara, C., Yilmaz, M., Ozgor, D. et al., Resveratrol, a red wine constituent polyphenol, protects gastric tissue against the oxidative stress in cholestatic rats. Dig. Dis. Sci. 2006, 51, 298-302.
27. Cenesiz, S., Yarim, G. F., Karabulut, A. B., Ara, C., Changing of antioxidant enzyme activity on the biliary obstructed rats treated with resveratrol. Dtsch. Tierarztl. Wochenschr. 2007, 114, 345-348.
28. Yuan, R. H., Chen, H. L., Hsu, M. K., Lee, P. H., Chang, M. H., Attenuation of Kupffer cell function in acute on chronic liver injury enhanced engraftment of transplanted hepatocytes. World J. Surg. 2007, 31, 1270-1277 (discussion 1278-1279).
29. Cheng, C. W., Duwaerts, C. C., Rooijen, N. V., Wintermeyer, P. et al., NK cells suppress experimental cholestatic liver injury by an interleukin-6-mediated, Kupffer cell-dependent mechanism. J. Hepatol. 2010.
30. Possamai, L. A., Antoniades, C. G., Anstee, Q. M., Quaglia, A. et al., Role of monocytes and macrophages in experimental and human acute liver failure. World J. Gastroenterol. 2010, 16, 1811-1819.
31. Harty, M. W., Papa, E. F., Huddleston, H. M., Young, E. et al., Hepatic macrophages promote the neutrophil-dependent resolution of fibrosis in repairing cholestatic rat livers. Surgery 2008, 143, 667-678.
32. Traeger, T., Mikulcak, M., Eipel, C., Abshagen, K. et al., Kupffer cell depletion reduces hepatic inflammation and apoptosis but decreases survival in abdominal sepsis. Eur. J. Gastroenterol. Hepatol. 2010, 22, 1039-1049.
33. + regulatory T cells. Int. Immunopharmacol. 2008, 8, 542-547.
34. Feng, Y. H., Zhou, W. L., Wu, Q. L., Li, X. Y. et al., Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol. Sin. 2002, 23, 893-897.
35. Fujita, J., Marino, M. W., Wada, H., Jungbluth, A. A. et al., Effect of TNF gene depletion on liver regeneration after partial hepatectomy in mice. Surgery 2001, 129, 48-54.
36. Shen, Z., Ajmo, J. M., Rogers, C. Q., Liang, X. et al., Role of SIRT1 in regulation of LPS- or two ethanol metabolites-induced TNF-alpha production in cultured macrophage cell lines. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G1047-G1053.
37. Gonzales, A. M., Orlando, R. A., Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr. Metabol. 2008, 5, 17.
38. Poli, G., Schaur, R. J., 4-Hydroxynonenal in the pathomechanisms of oxidative stress. IUBMB Life 2000, 50, 315-321.
39. Dubinina, E. E., Dadali, V. A., Role of 4-hydroxy-trans-2-nonenal in cell functions. Biochemistry (Mosc) 2010, 75, 1069-1087.
40. Riahi, Y., Cohen, G., Shamni, O., Sasson, S., Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 2010, 299, E879-E886.
41. Weng, S., Leng, X., Wei, Y., Interleukin-10 inhibits the activation of cultured rat hepatic stellate cells induced by Kupffer cells. Zhonghua Yi Xue Za Zhi 2002, 82, 104-107.
42. Reeves, H. L., Friedman, S. L., Activation of hepatic stellate cells - a key issue in liver fibrosis. Front. Biosci. 2002, 7, d808-d826.
43. Gabele, E., Brenner, D. A., Rippe, R. A., Liver fibrosis: signals leading to the amplification of the fibrogenic hepatic stellate cell. Front. Biosci. 2003, 8, d69-d77.
44. Ryhanen, L., Stenback, F., Ala-Kokko, L., Savolainen, E. R., The effect of malotilate on type III and type IV collagen, laminin and fibronectin metabolism in dimethylnitrosamine-induced liver fibrosis in the rat. J. Hepatol. 1996, 24, 238-245.
45. Arthur, M. J., Iredale, J. P., Mann, D. A., Tissue inhibitors of metalloproteinases: role in liver fibrosis and alcoholic liver disease. Alcohol Clin. Exp. Res. 1999, 23, 940-943.
46. Zamara, E., Novo, E., Marra, F., Gentilini, A. et al., 4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. J. Hepatol. 2004, 40, 60-68.
47. Zambon, A. C., Use of the Ki67 promoter to label cell cycle entry in living cells. Cytometry A 2010, 77, 564-570.
48. Souza, I. C., Martins, L. A., Coelho, B. P., Grivicich, I. et al., Resveratrol inhibits cell growth by inducing cell cycle arrest in activated hepatic stellate cells. Mol. Cell Biochem. 2008, 315, 1-7.
49. Chen, R. H., Chang, M. C., Su, Y. H., Tsai, Y. T., Kuo, M. L., Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J. Biol. Chem. 1999, 274, 23013-23019.
50. Xia, J. L., Dai, C., Michalopoulos, G. K., Liu, Y., Hepatocyte growth factor attenuates liver fibrosis induced by bile duct ligation. Am. J. Pathol. 2006, 168, 1500-1512.